Influence of pluronic F-68 on dissolution and bioavailability characteristics of multiple-layer pellets of nifedipine for controlled release delivery

Journal of Controlled Release

Volumn 68, Issue 3, 2000, Pages 433-440

  Ho, Hsiu O ^a   Chen, Chia Nan ^a   Sheu, Ming Thau ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Controlled release; Dissolution; Multiple layer; Nifedipine; Pellets; Pluronic F 68

Indexed keywords

CARDILATE SR; NIFEDIPINE; POLOXAMER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISPERSION; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; MALE; PELLET EXTRUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALGORITHMS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; HUMANS; MALE; NIFEDIPINE; POLOXAMER; SOLUBILITY; SOLUTIONS;

EID: 0034601670     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00281-9     Document Type: Article

References (13)

1. Davis S.S., Hardy J.G., Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut. 27:1986;886-892.
2. O'Reilly S., Wilson C.G., Hardy J.G. The influence of food on the gastric emptying of multiparticulate dosage forms. Int. J. Pharm. 34:1987;213-216.
3. Li S.P., Felt R.G., Paolo L.C., Haung M.Y., Williams III R.O. Development and in vitro-in vivo evaluation of a multiparticulate sustained release formulation of diltiazem. Pharm. Res. 12:1995;1338-1342.
4. Thombre A.G., DeNoto A.R., Falkner F.C., Lazar J.D. In vitro/in vivo correlations of sustained-release coated multiparticulate formulations of doxazosin. Int. J. Pharm. 111:1994;181-189.
5. P.M. Kotwal, S.A. Howard, Multilayered controlled release pharmaceutical dosage form, U.S. Patent 5, 474-786.
6. N. Shah, W. Phuapradil, A. Railkar, Colon-targeted delivery system, US Patent 5,482,718 (1996).
7. C.M. Chen, Diltiazem controlled release formulation, US Patent 5,567,441 (1996).
8. A.M. Mehta, Method of preparation of controlled release nifedipine formulations, US Patent 5,902,632 (1999).
9. D. Trigger, Pharmaceutical compositions containing nifedipine and process for the preparation, US Patent 5,594,013 (1997).
10. Weiner D.A. Calcium channel blockers. Med. Clin. Nor. Am. 72:1988;83-115.
11. DiPiro J.T. Controlling drug effects through improved oral formulations. Am. J. Med. 87:(suppl 2A):1989;31S-35S.
12. Prisant L.M., Bottini B., Dipiro J.T., Carr A.A. Novel drug-delivery systems for hypertension. Am. J. Med. 93:(suppl 2A):1992;45S-53S.
13. Ho H.O., Su H.L., Tsai T., Sheu M.T. The preparation and characterization of solid dispersion on pellets using a fluifized-bed system. Int. J. Pharm. 139:1996;223-229.